CAR-T Cell Therapy Expands Potential Beyond Cancer to Autoimmune Diseases
CAR-T cell therapy, initially developed for treating certain blood cancers, is now showing promise in addressing severe autoimmune diseases. This innovative treatment involves using a patient's own immune cells, which are genetically engineered to target and destroy malfunctioning immune cells. Dr. Vinod Balasa, a medical director at Valley Children’s Cancer and Blood Disorders Center, explains that unlike chemotherapy, which can affect normal cells, CAR-T therapy is highly targeted. Recent applications of this therapy have been tested on autoimmune diseases, with early results indicating the potential for long-lasting remission. A notable case involves a 47-year-old woman in Germany who, after years of battling multiple autoimmune diseases and exhausting other treatment options, received CAR-T therapy. Her condition improved significantly, allowing her to return to a normal life. This case highlights the therapy's potential to reset faulty immune systems by targeting B-cell-driven diseases, which are char... 
